Facephi Biometria Statistics

Total Valuation

BME:FACE has a market cap or net worth of EUR 62.92 million. The enterprise value is 69.24 million.

Market Cap	62.92M
Enterprise Value	69.24M

Important Dates

The next estimated earnings date is Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:FACE has 25.58 million shares outstanding. The number of shares has increased by 19.32% in one year.

Current Share Class	25.58M
Shares Outstanding	25.58M
Shares Change (YoY)	+19.32%
Shares Change (QoQ)	+24.96%
Owned by Insiders (%)	9.68%
Owned by Institutions (%)	16.77%
Float	23.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	246.00
PS Ratio	1.88
PB Ratio	3.28
P/TBV Ratio	8.51
P/FCF Ratio	131.62
P/OCF Ratio	86.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.79
EV / Sales	2.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	144.82

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.64.

Current Ratio	1.08
Quick Ratio	1.08
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	25.58
Interest Coverage	-3.96

Financial Efficiency

Return on equity (ROE) is -45.19% and return on invested capital (ROIC) is -11.69%.

Return on Equity (ROE)	-45.19%
Return on Assets (ROA)	-7.90%
Return on Invested Capital (ROIC)	-11.69%
Return on Capital Employed (ROCE)	-26.57%
Revenue Per Employee	143,605
Profits Per Employee	-38,130
Employee Count	233
Asset Turnover	0.70
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.51% in the last 52 weeks. The beta is 1.09, so BME:FACE's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	+25.51%
50-Day Moving Average	2.37
200-Day Moving Average	1.94
Relative Strength Index (RSI)	60.97
Average Volume (20 Days)	8,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:FACE had revenue of EUR 33.46 million and -8.88 million in losses. Loss per share was -0.35.

Revenue	33.46M
Gross Profit	28.62M
Operating Income	-6.03M
Pretax Income	-7.33M
Net Income	-8.88M
EBITDA	-5.48M
EBIT	-6.03M
Loss Per Share	-0.35

Full Income Statement

Balance Sheet

The company has 5.91 million in cash and 12.23 million in debt, giving a net cash position of -6.31 million or -0.25 per share.

Cash & Cash Equivalents	5.91M
Total Debt	12.23M
Net Cash	-6.31M
Net Cash Per Share	-0.25
Equity (Book Value)	19.19M
Book Value Per Share	0.76
Working Capital	2.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 724,430 and capital expenditures -246,362, giving a free cash flow of 478,068.

Operating Cash Flow	724,430
Capital Expenditures	-246,362
Free Cash Flow	478,068
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 85.55%, with operating and profit margins of -18.01% and -26.55%.

Gross Margin	85.55%
Operating Margin	-18.01%
Pretax Margin	-21.91%
Profit Margin	-26.55%
EBITDA Margin	-16.38%
EBIT Margin	-18.01%
FCF Margin	1.43%

Dividends & Yields

BME:FACE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.32%
Shareholder Yield	n/a
Earnings Yield	-14.12%
FCF Yield	0.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:FACE has an Altman Z-Score of 0.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.88
Piotroski F-Score	n/a